EARLY BREAST CANCER
Clinical trials for EARLY BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new EARLY BREAST CANCER trials appear
Sign up with your email to follow new studies for EARLY BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Home infusion preferred by many in breast cancer study
Symptom relief CompletedThis study looked at whether people with HER2-positive breast cancer prefer getting their medication at home or in the hospital. About 346 participants were randomly assigned to receive treatment in both settings and then asked which they liked more. The goal was to see if home t…
Matched conditions: EARLY BREAST CANCER
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Symptom relief
Last updated Jun 16, 2026 12:55 UTC
-
Skin troubles from breast cancer treatment: a hidden burden on daily life
Knowledge-focused CompletedThis study involved 155 women with early breast cancer who had been taking hormone therapy for 2-3 years. Researchers wanted to understand how skin-related side effects from the treatment impact their quality of life. Participants filled out questionnaires about their skin sympto…
Matched conditions: EARLY BREAST CANCER
Sponsor: Pierre Fabre Medicament • Aim: Knowledge-focused
Last updated Jun 17, 2026 03:15 UTC
-
Young breast cancer patients share feelings on fertility risks
Knowledge-focused CompletedThis study surveyed 385 women aged 35 or younger with early-stage breast cancer to learn how they feel about the risk of losing fertility due to chemotherapy. The goal was to understand their attitudes and help doctors plan treatments that respect their concerns. No treatment was…
Matched conditions: EARLY BREAST CANCER
Phase: NA • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Knowledge-focused
Last updated Jun 17, 2026 03:12 UTC
-
Immune clues in tumors could forecast chemo outcomes
Knowledge-focused CompletedThis study looked at 171 women with early breast cancer to see if immune cells inside tumors are linked to how well chemotherapy works. Researchers also checked if these immune markers relate to cancer DNA in the blood. The goal was to find better ways to predict treatment respon…
Matched conditions: EARLY BREAST CANCER
Sponsor: Institute of Oncology Ljubljana • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:55 UTC
-
Immune cell analysis in 3,646 breast cancer patients reveals clues about survival
Knowledge-focused CompletedThis study looked at immune cells called TILs and CD8+ T cells in tumor samples from 3,646 women with early-stage breast cancer who had chemotherapy after surgery. The goal was to see if these cells are linked to how long patients live without the cancer coming back. The research…
Matched conditions: EARLY BREAST CANCER
Sponsor: Hellenic Cooperative Oncology Group • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:06 UTC
-
Scientists Re-Analyze old samples to unlock secrets of HER2-Low breast cancer
Knowledge-focused CompletedThis study looked at tissue samples from 2751 early breast cancer patients who had already completed chemotherapy. Researchers wanted to see if tumors with low levels of HER2 protein are biologically different from those with no HER2 at all. They used genetic testing and protein …
Matched conditions: EARLY BREAST CANCER
Sponsor: Hellenic Cooperative Oncology Group • Aim: Knowledge-focused
Last updated Jun 09, 2026 12:10 UTC